Cargando…
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929236/ https://www.ncbi.nlm.nih.gov/pubmed/32067690 http://dx.doi.org/10.1016/j.annonc.2020.01.002 |
| _version_ | 1784670818756722688 |
|---|---|
| author | Clarke, N.W. Ali, A. Ingleby, F.C. Hoyle, A. Amos, C.L. Attard, G. Brawley, C.D. Calvert, J. Chowdhury, S. Cook, A. Cross, W. Dearnaley, D.P. Douis, H. Gilbert, D. Gillessen, S. Jones, R.J. Langley, R.E. MacNair, A. Malik, Z. Mason, M.D. Matheson, D. Millman, R. Parker, C.C. Ritchie, A.W.S. Rush, H. Russell, J.M. Brown, J. Beesley, S. Birtle, A. Capaldi, L. Gale, J. Gibbs, S. Lydon, A. Nikapota, A. Omlin, A. O’Sullivan, J.M. Parikh, O. Protheroe, A. Rudman, S. Srihari, N.N. Simms, M. Tanguay, J.S. Tolan, S. Wagstaff, J. Wallace, J. Wylie, J. Zarkar, A. Sydes, M.R. Parmar, M.K.B. James, N.D. |
| author_facet | Clarke, N.W. Ali, A. Ingleby, F.C. Hoyle, A. Amos, C.L. Attard, G. Brawley, C.D. Calvert, J. Chowdhury, S. Cook, A. Cross, W. Dearnaley, D.P. Douis, H. Gilbert, D. Gillessen, S. Jones, R.J. Langley, R.E. MacNair, A. Malik, Z. Mason, M.D. Matheson, D. Millman, R. Parker, C.C. Ritchie, A.W.S. Rush, H. Russell, J.M. Brown, J. Beesley, S. Birtle, A. Capaldi, L. Gale, J. Gibbs, S. Lydon, A. Nikapota, A. Omlin, A. O’Sullivan, J.M. Parikh, O. Protheroe, A. Rudman, S. Srihari, N.N. Simms, M. Tanguay, J.S. Tolan, S. Wagstaff, J. Wallace, J. Wylie, J. Zarkar, A. Sydes, M.R. Parmar, M.K.B. James, N.D. |
| author_sort | Clarke, N.W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8929236 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89292362022-03-25 Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003 Clarke, N.W. Ali, A. Ingleby, F.C. Hoyle, A. Amos, C.L. Attard, G. Brawley, C.D. Calvert, J. Chowdhury, S. Cook, A. Cross, W. Dearnaley, D.P. Douis, H. Gilbert, D. Gillessen, S. Jones, R.J. Langley, R.E. MacNair, A. Malik, Z. Mason, M.D. Matheson, D. Millman, R. Parker, C.C. Ritchie, A.W.S. Rush, H. Russell, J.M. Brown, J. Beesley, S. Birtle, A. Capaldi, L. Gale, J. Gibbs, S. Lydon, A. Nikapota, A. Omlin, A. O’Sullivan, J.M. Parikh, O. Protheroe, A. Rudman, S. Srihari, N.N. Simms, M. Tanguay, J.S. Tolan, S. Wagstaff, J. Wallace, J. Wylie, J. Zarkar, A. Sydes, M.R. Parmar, M.K.B. James, N.D. Ann Oncol Corrigendum Oxford University Press 2020-03 2020-01-31 /pmc/articles/PMC8929236/ /pubmed/32067690 http://dx.doi.org/10.1016/j.annonc.2020.01.002 Text en © 2020 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Corrigendum Clarke, N.W. Ali, A. Ingleby, F.C. Hoyle, A. Amos, C.L. Attard, G. Brawley, C.D. Calvert, J. Chowdhury, S. Cook, A. Cross, W. Dearnaley, D.P. Douis, H. Gilbert, D. Gillessen, S. Jones, R.J. Langley, R.E. MacNair, A. Malik, Z. Mason, M.D. Matheson, D. Millman, R. Parker, C.C. Ritchie, A.W.S. Rush, H. Russell, J.M. Brown, J. Beesley, S. Birtle, A. Capaldi, L. Gale, J. Gibbs, S. Lydon, A. Nikapota, A. Omlin, A. O’Sullivan, J.M. Parikh, O. Protheroe, A. Rudman, S. Srihari, N.N. Simms, M. Tanguay, J.S. Tolan, S. Wagstaff, J. Wallace, J. Wylie, J. Zarkar, A. Sydes, M.R. Parmar, M.K.B. James, N.D. Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003 |
| title | Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003 |
| title_full | Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003 |
| title_fullStr | Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003 |
| title_full_unstemmed | Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003 |
| title_short | Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003 |
| title_sort | corrigendum to addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the stampede trial: ann oncol 2019; 30: 1992–2003 |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929236/ https://www.ncbi.nlm.nih.gov/pubmed/32067690 http://dx.doi.org/10.1016/j.annonc.2020.01.002 |
| work_keys_str_mv | AT clarkenw corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT alia corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT inglebyfc corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT hoylea corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT amoscl corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT attardg corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT brawleycd corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT calvertj corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT chowdhurys corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT cooka corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT crossw corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT dearnaleydp corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT douish corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT gilbertd corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT gillessens corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT jonesrj corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT langleyre corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT macnaira corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT malikz corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT masonmd corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT mathesond corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT millmanr corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT parkercc corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT ritchieaws corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT rushh corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT russelljm corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT brownj corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT beesleys corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT birtlea corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT capaldil corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT galej corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT gibbss corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT lydona corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT nikapotaa corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT omlina corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT osullivanjm corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT parikho corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT protheroea corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT rudmans corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT sriharinn corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT simmsm corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT tanguayjs corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT tolans corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT wagstaffj corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT wallacej corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT wyliej corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT zarkara corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT sydesmr corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT parmarmkb corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT jamesnd corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 AT corrigendumtoadditionofdocetaxeltohormonaltherapyinlowandhighburdenmetastatichormonesensitiveprostatecancerlongtermsurvivalresultsfromthestampedetrialannoncol20193019922003 |